Literature DB >> 20427663

Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Erica Bowton1, Christine Saunders, Kevin Erreger, Dhananjay Sakrikar, Heinrich J Matthies, Namita Sen, Tammy Jessen, Roger J Colbran, Marc G Caron, Jonathan A Javitch, Randy D Blakely, Aurelio Galli.   

Abstract

The neurotransmitter dopamine (DA) modulates brain circuits involved in attention, reward, and motor activity. Synaptic DA homeostasis is primarily controlled via two presynaptic regulatory mechanisms, DA D(2) receptor (D(2)R)-mediated inhibition of DA synthesis and release, and DA transporter (DAT)-mediated DA clearance. D(2)Rs can physically associate with DAT and regulate DAT function, linking DA release and reuptake to a common mechanism. We have established that the attention-deficit hyperactivity disorder-associated human DAT coding variant Ala559Val (hDAT A559V) results in anomalous DA efflux (ADE) similar to that caused by amphetamine-like psychostimulants. Here, we show that tonic activation of D(2)R provides support for hDAT A559V-mediated ADE. We determine in hDAT A559V a pertussis toxin-sensitive, CaMKII-dependent phosphorylation mechanism that supports D(2)R-driven DA efflux. These studies identify a signaling network downstream of D(2)R activation, normally constraining DA action at synapses, that may be altered by DAT mutation to impact risk for DA-related disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427663      PMCID: PMC2881830          DOI: 10.1523/JNEUROSCI.5094-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  Regulation of effectors by G-protein alpha- and beta gamma-subunits. Recent insights from studies of the phospholipase c-beta isoenzymes.

Authors:  A J Morris; S Scarlata
Journal:  Biochem Pharmacol       Date:  1997-08-15       Impact factor: 5.858

2.  Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area.

Authors:  M J Nirenberg; J Chan; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

3.  Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal.

Authors:  G J Wang; N D Volkow; J S Fowler; J Logan; N N Abumrad; R J Hitzemann; N S Pappas; K Pascani
Journal:  Neuropsychopharmacology       Date:  1997-02       Impact factor: 7.853

4.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

Review 5.  Molecular characterization of the dopamine transporter.

Authors:  B Giros; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1993-02       Impact factor: 14.819

6.  Norepinephrine transporters have channel modes of conduction.

Authors:  A Galli; R D Blakely; L J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Bidirectional regulation of DARPP-32 phosphorylation by dopamine.

Authors:  A Nishi; G L Snyder; P Greengard
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

8.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.

Authors:  B Giros; M Jaber; S R Jones; R M Wightman; M G Caron
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

9.  Protein kinase C and dopamine transport--2. Effects of amphetamine in vitro.

Authors:  C T Giambalvo
Journal:  Neuropharmacology       Date:  1992-12       Impact factor: 5.250

10.  In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.

Authors:  G D Pearlson; D F Wong; L E Tune; C A Ross; G A Chase; J M Links; R F Dannals; A A Wilson; H T Ravert; H N Wagner
Journal:  Arch Gen Psychiatry       Date:  1995-06
View more
  59 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

3.  Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.

Authors:  Luke R Gabriel; Sijia Wu; Patrick Kearney; Karl D Bellvé; Clive Standley; Kevin E Fogarty; Haley E Melikian
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

Review 4.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 5.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 6.  Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.

Authors:  George Khelashvili; Harel Weinstein
Journal:  Biochim Biophys Acta       Date:  2015-04-04

7.  Identifying novel members of the Wntless interactome through genetic and candidate gene approaches.

Authors:  Jessica Petko; Trevor Tranchina; Goral Patel; Robert Levenson; Stephanie Justice-Bitner
Journal:  Brain Res Bull       Date:  2017-07-20       Impact factor: 4.077

8.  Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

Authors:  Freja Herborg; Thorvald F Andreassen; Frida Berlin; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

9.  Single Quantum Dot Tracking Illuminates Neuroscience at the Nanoscale.

Authors:  Oleg Kovtun; Ian D Tomlinson; Danielle M Bailey; Lucas B Thal; Emily J Ross; Lauren Harris; Michael P Frankland; Riley S Ferguson; Zachary Glaser; Jonathan Greer; Sandra J Rosenthal
Journal:  Chem Phys Lett       Date:  2018-06-19       Impact factor: 2.328

10.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.